<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03332316</url>
  </required_header>
  <id_info>
    <org_study_id>R17104M</org_study_id>
    <secondary_id>2017-002185-51</secondary_id>
    <nct_id>NCT03332316</nct_id>
  </id_info>
  <brief_title>Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery</brief_title>
  <official_title>Effect of Perineural Dexamethasone on the Duration of Popliteal Nerve Block for Anesthesia After Ankle Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Effect of perineural dexamethasone on the duration of popliteal nerve block after ankle/foot
      surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is proposed to explore the effect of perineural dexamethasone on the duration of
      popliteal nerve block for analgesia after ankle surgery.

      After ankle or foot arthrodesis patients need a good analgesia. Nevertheless early
      mobilisation and discharge are important for the healing process after surgery. Peripheral
      nerve blocks have provided a safe, effective method to control early postoperative pain when
      symptoms are most severe. Perineural dexamethasone added to local anesthetic prolongs the
      duration of analgesia of the perineural nerve block.

      The perineural use of dexamethasone is still off-label. There is a ongoing discussion of
      which has better benefits, intravenous or perineural dexamethasone.

      There are multiple research where the intravenous and perineural dexamethasone use has
      compared, but there is still a limited amount of research of low dose perineural
      dexamethasone versus intravenous dexamethasone.

      In this study investigators compare different doses of perineural dexamethasone added to
      ropivacaine 2 mg/ml 20ml. After arthrodesis under spinal anaesthesia the patients receive
      popliteal block ropivacaine 2 mg/ml 20 ml and dexamethasone of different doses. Groups 1 to 4
      has dexamethasone doses 0, 2mg, 3mg or 4 mg.

      After the popliteal nerve block investigators follow postoperative pain, opiate consumption,
      mobilisation and long term quality of life.

      Investigators goal is to find a dexamethasone dose which is as low as possible but at the
      same time covers the need for a good pain relief and fast recovery postoperatively.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2, 2017</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First need of opiate</measure>
    <time_frame>48 hours</time_frame>
    <description>Time after surgery when the patient needs opiate for the first time</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Opiate consumption</measure>
    <time_frame>48 hours</time_frame>
    <description>Total opiate consumption after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>postoperatively: at 4 hours, at 8 hours,at 12 hours, at 16 hours, at 20 hours, at 24 hours, at 28 hours, 32 hours, at 36 hours, at 40 hours, at 44 hours, at 48 hours,seventh postoperative day</time_frame>
    <description>Numeric rating scale NRS 0-10</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilisation</measure>
    <time_frame>postoperatively: at 4 hours, at 8 hours,at 12 hours, at 16 hours, at 20 hours, at 24 hours, at 28 hours, 32 hours, at 36 hours, at 40 hours, at 44 hours, at 48 hours</time_frame>
    <description>Toe movement every 4 hour during hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood glucose</measure>
    <time_frame>postoperatively: at 4 hours, at 8 hours,at 12 hours, at 16 hours, at 20 hours, at 24 hours</time_frame>
    <description>Blood glucose every 4 hour during hospitalization</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Quality of life (EQ-5D-3L) -query</measure>
    <time_frame>Before operation and 6-8 weeks, 6 months, 12 months postoperatively</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>McGill -pain query</measure>
    <time_frame>Before operation and 6-8 weeks, 6 months, 12 months postoperatively</time_frame>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Nerve Block</condition>
  <arm_group>
    <arm_group_label>DEXA0</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Ropivacaine Hydrochloride Inj 2mg/ml 20 ml and Sodium Chloride 9mg/mL 1 ml perineurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEXA1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine Hydrochloride Inj 2 mg/ml 20 ml and Dexamethasone Sodium Phosphate 5mg/ml 0,2 ml and Sodium Chloride 9mg/mL 0,8 ml perineurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEXA2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine Hydrochloride Inj 2 mg/ml 20 ml and Dexamethasone Sodium Phosphate 5mg/ml 0,4 ml and Sodium Chloride 9mg/mL 0,6 ml perineurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DEXA4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ropivacaine Hydrochloride Inj 2 mg/ml 20 ml and Dexamethasone Sodium Phosphate 5mg/ml 0,8 ml and Sodium Chloride 9mg/mL 0,2 ml perineurally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone Sodium Phosphate</intervention_name>
    <description>Dexamethasone injection</description>
    <arm_group_label>DEXA1</arm_group_label>
    <arm_group_label>DEXA2</arm_group_label>
    <arm_group_label>DEXA4</arm_group_label>
    <other_name>Oradexon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hydrochloride Inj 2 mg/ml</intervention_name>
    <description>Ropivacaine injection</description>
    <arm_group_label>DEXA0</arm_group_label>
    <arm_group_label>DEXA1</arm_group_label>
    <arm_group_label>DEXA2</arm_group_label>
    <arm_group_label>DEXA4</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride 9mg/mL</intervention_name>
    <description>Sodium Chloride injection</description>
    <arm_group_label>DEXA0</arm_group_label>
    <arm_group_label>DEXA1</arm_group_label>
    <arm_group_label>DEXA2</arm_group_label>
    <arm_group_label>DEXA4</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Adult people under ankle/foot arthrodesis as a curative therapy of ankle arthrosis or
        situation after ankle injury or malposition

        Exclusion Criteria:

        Age under 18 years Complicated diabetes mellitus Lack of finnish language skill and/or
        co-operation Chronic pain Steroid medication in regular use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maija-Liisa Kalliomäki, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Tampere University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maija-Liisa Kalliomäki, PhD</last_name>
    <phone>+358 3 311 69424</phone>
    <email>maija-liisa.kalliomaki@pshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jenni Kanerva, PhD</last_name>
    <phone>+358 3 311 67415</phone>
    <email>jenni.kanerva@pshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <zip>33521</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maija-Liisa Kalliomäki, PhD</last_name>
      <phone>+358 3 311 69424</phone>
      <email>maija-liisa.kalliomaki@pshp.fi</email>
    </contact>
    <contact_backup>
      <last_name>Jenni Kanerva, PhD</last_name>
      <phone>+358 3 311 67415</phone>
      <email>jenni.kanerva@pshp.fi</email>
    </contact_backup>
    <investigator>
      <last_name>Suvi Kastikainen, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jenni Kanerva, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2017</study_first_submitted>
  <study_first_submitted_qc>November 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

